Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein

Virus Research

Volumn 74, Issue 1-2, 2001, Pages 133-137

  Cusi, Maria Grazia ^a   Fischer, Susanne ^b   Sedlmeier, Reinhard ^b   Valassina, Marcello ^a   Valensin, Pier Egisto ^a   Donati, Marco ^a   Neubert, Wolfgang Jens ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEMAGGLUTINATION INHIBITING ANTIBODY; HN PROTEIN; MEASLES MUMPS VACCINE; NEUTRALIZING ANTIBODY; SYNTHETIC PEPTIDE;

ARTICLE; HUMORAL IMMUNITY; IMMUNOBLOTTING; MOUSE; MUMPS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VIRUS CELL INTERACTION; VIRUS EXPRESSION; VIRUS HEMAGGLUTINATION; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CELL LINE; CERCOPITHECUS AETHIOPS; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; FEMALE; HELA CELLS; HN PROTEIN; HUMANS; MICE; MICE, INBRED BALB C; MUMPS VACCINE; MUMPS VIRUS; NEURAMINIDASE; NEUTRALIZATION TESTS; PEPTIDES; VERO CELLS;

MUMPS VIRUS;

EID: 0035117726     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(00)00254-9     Document Type: Article

References (26)

1. Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps Urabe vaccine strain
2. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits
3. Synthetic peptide as antigens: Pitfalls of conjugation methods
4. The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease
5. Genetic studies on a mumps vaccine strain associated with meningitis
6. Single-step method of RNA isolation by acid guanidinium thiocyante-phenol-chloroform extraction
7. Prediction of protein conformation
8. Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in wild-type strains of mumps virus is the most relevant marker of virulence
9. Sendai virus protein-protein interactions studied by a protein-blotting protein-overlay technique: Mapping of domains on NP protein required for binding to P protein
10. Protection of hamsters against experimental mumps virus (MuV) infection by antibodies raised against the MuV surface glycoproteins expressed from recombinant vaccinia vectors
11. Identification of the V1 region as a linear neutralizing epitope of the simian immunodeficiency virus SIV mac envelope glycoprotein
12. Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1
13. Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus
14. New mammalian expression vectors
15. Identification of paramyxovirus specific haemolysis-inhibiting antibodies separate from haemagglutinating-inhibiting and neuraminidase-inhibiting antibodies
16. The reactions of monoclonal antibodies with structural proteins of mumps virus
17. Characterization of genotype-specific epitopes of the HN protein of mumps virus
18. Identificationof multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein
19. Immunogenicity of a peptide from a major neutralizing determinant of the feline immunodeficiency virus surface glycoprotein
20. Ability of linear and cyclic peptides of neutralization antigenic site 1 of poliovirus type 1 to induce cross-reactive and neutralizing antibodies
21. D-pepetides as immunogens and diagnostic reagents
22. Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis
23. Mumps virus
24. Antigenic and genetic variation of the HN protein of mumps virus strains
25. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice